Jane Street’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Jane Street’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-21,629	Closed	-$111K	–	3221
2013 Q3	$111K	Buy	+21,629	New	+$102K	﹤0.01%	2533

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jane Street's ALXA Position: Q4 2013 in Review

Jane Street sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2013, closing a stake of 21,629 shares — an estimated $111K sold.

Jane Street first reported a position in ALXA in Q3 2013 and held it in 1 quarter. The position peaked at $111K in Q3 2013. 41 funds tracked by Wall St. Rank hold ALXA as of Q4 2013.

Jane Street reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
Jane Street sold 21,629 Alexza Pharmaceuticals Inc shares in Q4 2013, an estimated $111K.
Jane Street first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 1 quarter.
Jane Street's Alexza Pharmaceuticals Inc position peaked at $111K in Q3 2013.
41 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2013.

Based on Jane Street's 13F filing for Q4 2013, filed 14 Feb 2014.